Cargando…

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

Background The concept of combinational analysis between the methylation of O (6) -methylguanine-DNA methyltransferase ( MGMT ) and telomerase reverse transcriptase promoter ( pTERT ) mutation in glioblastoma (GBM) has been reported. The main study objective was to determine the prognosis of patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tunthanathip, Thara, Sangkhathat, Surasak, Tanvejsilp, Pimwara, Kanjanapradit, Kanet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559075/ https://www.ncbi.nlm.nih.gov/pubmed/34744391 http://dx.doi.org/10.1055/s-0041-1735821

Ejemplares similares

Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Risk Factors Associated with Malignant Transformation of Astrocytoma: Competing Risk Regression Analysis
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Risk Factors Associated with Malignant Transformation of Astrocytoma: Competing Risk Regression Analysis
por: Tunthanathip, Thara, et al.
Publicado: (2022)

Glioblastoma Multiforme Associated with Arteriovenous Malformation: A Case Report and Literature Review
por: Tunthanathip, Thara, et al.
Publicado: (2020)

Survival and Prognostic Factors in Pediatric Patients with Medulloblastoma in Southern Thailand
por: Nalita, Navaporn, et al.
Publicado: (2018)

Juvenile Hyaline Fibromatosis: Report of a Case with a Novel ANTXR2 Gene Mutation
por: Choochuen, Pongsakorn, et al.
Publicado: (2022)

Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer
por: Bejrananda, Tanan, et al.
Publicado: (2021)

Spinal capillary hemangiomas: Two cases reports and review of the literature
por: Tunthanathip, Thara, et al.
Publicado: (2017)

Molecular dynamic simulation of mutated β-catenin in solid pseudopapillary neoplasia of the pancreas
por: Tipmanee, Varomyalin, et al.
Publicado: (2018)

Predicting the Health-related Quality of Life in Patients Following Traumatic Brain Injury
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Quality of life, out-of-pocket expenditures, and indirect costs among patients with the central nervous system tumors in Thailand
por: Tunthanathip, Thara, et al.
Publicado: (2022)

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
por: Arita, Hideyuki, et al.
Publicado: (2016)

Multiple, Primary Brain Tumors with Diverse Origins and Different Localizations: Case Series and Review of the Literature
por: Tunthanathip, Thara, et al.
Publicado: (2018)

Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma
por: Sasaki, Takahiro, et al.
Publicado: (2019)

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021)

The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI‐derived and clinical features, predict adult primary glioblastoma survival
por: Shu, Chang, et al.
Publicado: (2018)

The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma
por: Hsu, Chih-Yi, et al.
Publicado: (2017)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients
por: Giunco, S., et al.
Publicado: (2023)

MGMT promoter methylation in Peruvian patients with glioblastoma
por: Belmar-Lopez, Carolina, et al.
Publicado: (2018)

Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect
por: Gibson, David, et al.
Publicado: (2023)

An evaluation of MGMT promoter methylation within the methylation subclasses of glioblastoma
por: Alnahhas, Iyad, et al.
Publicado: (2020)

IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
por: Yang, Pei, et al.
Publicado: (2015)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region
por: Kanemoto, Manabu, et al.
Publicado: (2014)

Prognostic Role of Methylation Status of the MGMT Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
por: Kim, Dae Cheol, et al.
Publicado: (2016)

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
por: Vuong, Huy Gia, et al.
Publicado: (2020)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
por: Melguizo, Consolación, et al.
Publicado: (2012)

Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
por: Thon, Niklas, et al.
Publicado: (2013)

Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation
por: Kim, Se-Hyuk, et al.
Publicado: (2018)

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
por: Smrdel, Uros, et al.
Publicado: (2016)

The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
por: Jovanović, Nikola, et al.
Publicado: (2019)

Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022)

MGMT Promoter Methylation: Prognostication beyond Treatment Response
por: Ashkan, Keyoumars, et al.
Publicado: (2023)

Identifying the optimal cutoff point for MGMT promoter methylation status in glioblastoma
por: Nguyen, Ngan, et al.
Publicado: (2021)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
por: Kristensen, Lasse S., et al.
Publicado: (2016)

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
por: Yin, An-an, et al.
Publicado: (2014)

A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
por: Cheng, Wen, et al.
Publicado: (2015)

NGMA-6. Quantitative MGMT Promoter Methylation Index Indicates Non-Linear, Prognostic Effect in Glioblastoma
por: Gibson, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sejs4h5d6k9uog7qbv1q4vm93i